64 related articles for article (PubMed ID: 1893465)
21. Immune condition in patients with Hodgkin's disease.
Zywicka-Lopaciuk H; Konopka L; Traczyk Z; Pawelski S; Sylwestrowicz T; Maślanka K; Arczyńska-Brojer E; Cieśluk S; Karpowicz M; Małkowska-Zwierz W
Arch Immunol Ther Exp (Warsz); 1980; 28(1):153-60. PubMed ID: 6968189
[TBL] [Abstract][Full Text] [Related]
22. Cytokine gene expression profile distinguishes CD4+/CD57+ T cells of the nodular lymphocyte predominance type of Hodgkin's lymphoma from their tonsillar counterparts.
Atayar C; Poppema S; Visser L; van den Berg A
J Pathol; 2006 Feb; 208(3):423-30. PubMed ID: 16353293
[TBL] [Abstract][Full Text] [Related]
23. Differential recovery of circulating T cell subsets after nodal irradiation for Hodgkin's disease.
Haas GS; Halperin E; Doseretz D; Linggood R; Russell PS; Colvin R; Barrett L; Cosimi AB
J Immunol; 1984 Feb; 132(2):1026-30. PubMed ID: 6361130
[TBL] [Abstract][Full Text] [Related]
24. Immunological markers of peripheral blood and lymph node lymphocytes in Hodgkin's disease.
González M; Hernández F; San Miguel JF; Moraleda JM; Caballero MD; López Borrasca A
Neoplasma; 1985; 32(2):191-8. PubMed ID: 4000308
[TBL] [Abstract][Full Text] [Related]
25. [Immunity and hypersensitivity in Hodgkin's lymphoma].
Leoni P; Marchegiani G; Montillo M; Centurioni R; Montroni M; Danieli G
Minerva Med; 1982 May; 73(20):1361-9. PubMed ID: 6210855
[No Abstract] [Full Text] [Related]
26. [The evaluation of peripheral blood lymphoid cells in children in remission a year after the cessation of treatment for acute lymphoblastic leukemia and non-Hodgkin's lymphoma type non-B].
Wylezoł I; Mazur B; Sońta-Jakimczyk D; Olejnik I
Wiad Lek; 1998; 51 Suppl 4():140-4. PubMed ID: 10731958
[TBL] [Abstract][Full Text] [Related]
27. Preliminary evaluation of immunotherapy in patients with Hodgkin's disease.
Zywicka-Lopaciuk H; Konopka L; Karpowicz M; Sylwestrowicz T; Maślanka K; Arczyńska-Brojer E; Cieśluk S; Małkowska-Zwierz W; Pawelski S
Arch Immunol Ther Exp (Warsz); 1981; 29(6):739-55. PubMed ID: 7349093
[TBL] [Abstract][Full Text] [Related]
28. [Presence of cells with a high content of DNA in the circulating blood of 2 patients with malignant lymphoma. Blastic response of blood lymphocytes to PHA].
Chilosi M; Nigro M
Pathologica; 1974; 66(957-958):287-93. PubMed ID: 4453436
[No Abstract] [Full Text] [Related]
29. Lymphocyte transformation and production of a human mononuclear leucocyte chemotactic factor in patients with Hodgkin's disease.
Rühl H; Vogt W; Bochert G; Schmidt S; Schaoua H; Moelle R
Clin Exp Immunol; 1974 Jul; 17(3):407-15. PubMed ID: 4468860
[TBL] [Abstract][Full Text] [Related]
30. Immunologic status of children with Hodgkin's disease (HD).
Bogusławska-Jaworska J; Chybicka A; Pisarek J
Arch Immunol Ther Exp (Warsz); 1981; 29(6):725-31. PubMed ID: 6983869
[TBL] [Abstract][Full Text] [Related]
31. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
[TBL] [Abstract][Full Text] [Related]
32. Nuclear morphology and morphometry of B-lymphocyte transformation. Implications for follicular center cell lymphomas.
Dardick I; Sinnott NM; Hall R; Bajenko-Carr TA; Setterfield G
Am J Pathol; 1983 Apr; 111(1):35-49. PubMed ID: 6340518
[TBL] [Abstract][Full Text] [Related]
33. Spleen lymphocyte populations in patients with Hodgkin's disease--properties of cells with different densities.
Rocha B; Ferreira AA; Munn G; de Sousa M; Freitas AA
Clin Exp Immunol; 1982 May; 48(2):300-6. PubMed ID: 7105487
[TBL] [Abstract][Full Text] [Related]
34. Transfer factor in Hodgkin's disease: a randomized clinical and immunological study.
Hancock BW; Bruce L; Sokol RJ; Clark A
Eur J Cancer Clin Oncol; 1988 May; 24(5):929-33. PubMed ID: 3049116
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical determination of CD23 expression in Hodgkin's disease using paraffin sections.
Rowlands DC; Hansel TT; Crocker J
J Pathol; 1990 Mar; 160(3):239-43. PubMed ID: 2139890
[TBL] [Abstract][Full Text] [Related]
36. Transfer factor in Hodgkin's disease.
Ng RP; Moran CJ; Alexopoulos CG; Bellingham AJ
Lancet; 1975 Nov; 2(7941):901-3. PubMed ID: 53376
[TBL] [Abstract][Full Text] [Related]
37. [The origin and clonal proliferation of malignant altered cells in Hodgkin's disease].
Krizanac-Bengez L; Boranic M
Lijec Vjesn; 1990; 112(1-2):50-2. PubMed ID: 2366621
[TBL] [Abstract][Full Text] [Related]
38. [Effect of radiochemotherapy and splenectomy on lymphoid subclasses in patients with Hodgkin's lymphoma in complete remission].
Leoni P; Montroni M; Montillo M; Salvi A; Centurioni R; Fanciulli E
G Clin Med; 1981 Oct; 62(10):685-92. PubMed ID: 6977469
[No Abstract] [Full Text] [Related]
39. Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis.
Hudnall SD; Patel J; Schwab H; Martinez J
Cytometry B Clin Cytom; 2003 Sep; 55(1):22-8. PubMed ID: 12949956
[TBL] [Abstract][Full Text] [Related]
40. Autologous rosette-forming capacity of T-lymphocytes in Hodgkin's disease.
Bodolay E; Berényi E; Sonkoly I; Szegedi G
Acta Med Hung; 1984; 41(2-3):113-9. PubMed ID: 6611543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
